Skip to main content

Pharmacists at the frontline beating the COVID-19 pandemic


As the lockdowns are being observed all over the globe and the national level pharmacy professionals are performing frontline roles, this editorial highlights the role of pharmacists in the COVID − 19 pandemic. Pharmacists globally are providing services amidst pandemic, including TRIAGE services, seeing patients and reducing the patients’ burden on health care facilities such as hospitals and GP practices. Pharmacists are also working to providing home deliveries, as well as dealing with the increasing number of patients coming through to pharmacies with the other ailments. Pharmacy associations have issued their guidelines and in this editorial, several global examples of pharmacists’ role in the COVID 19 are being discussed. Pakistan is used as a country case study in this editorial. The editorial also elaborates how pharmacists in the UK and Pakistan have teamed up together to compile 10-steps protection guidelines for the pharmacy teams in Pakistan in English and Urdu language. This 10-point guidance educates community pharmacies for safety and standard operation as the number of patients in the country continues to rise. These guidelines are endorsed by the government and private bodies. These can be adopted and adapted by any country; keeping in view their laws and regulations.


Pharmacists and Covid-19 pandemic

Through public preventative measures advocated by WHO, the public are working together in their respective countries to ‘flatten the curve’. With a near enough global lockdown there seems to be an even greater dependence on pharmacists as the first point of contact to fulfil the public’s healthcare needs. Pharmacies around the world are one of the few places that are kept open for public service even during the strict lockdowns [1].

Community pharmacists and their teams are a vital healthcare provider during the outbreak; they remain on the frontline of public health by serving as direct points of access for their patients. Hospital pharmacists have an important role during the outbreak in infection control as well as patient care and support [2].

Countries severely hit by pandemic are exceedingly facing overburdened Health facilities and shortages as well as burnouts of health care professionals. TRIAGE service has emerged as a supportive modality in this time of crisis which includes pharmacists along with other primary health care workers [3]. A provision of COVID-19 trained health care professionals exists for supporting these services in the time of shortage of medical and nursing staff members and to increase the outreach of the service in Australia as well. The International Pharmaceutical Federation (FIP) has issued a pack of 10 summaries for guidance on COVID-19 [4]. American Pharmacist Association (APhA) has also issued guidelines and resource documents for the strengthening and preparedness of the community pharmacies as front line health care workers in the global health crisis [5].

Reliability of information and control of scare and misinformation are important concerns during the worldwide spread of the disease. Community pharmacists also continue to play their role towards public uninterrupted for regular supplies of medicines, as well as supporting governments [6] for disseminating information on precautions related to COVID-19 spread including hand washing technique to availability of face masks and instructions for their proper use and disposal. USP has issued guidelines for the compounding and pharmacists and manufacturers for preparation of hand sanitizers to cope with the stock outs [7].

The community pharmacy has a unique credible role with ease in accessibility. In France, the campaign against domestic violence also involved the use of the code “Mask 19” to report domestic violence by the victims [8]. Pharmacists are an integral component of healthcare performing extraordinary roles in the earlier pandemics and health crisis, with some like Ebola and Zika posing global health security risks as well [2]. Likewise, by contributing in the prevention, preparedness and response to COVID-19 pandemic community pharmacists are delivering their role towards public health in dealing with this crisis [9]. In many countries, pharmacies have worked in close collaboration with the International humanitarian organizations like Red Cross and local community workers to increase its outreach to public and ensure home delivery of medicines [10].

In New Zealand, the pharmacist’s contribution is appreciated by the government by extra remuneration for their support. Hotline numbers have been issued for encouraging on phone consultation and prescription orders for home supplies to reduce public visits which are to be avoided in case of suspected and confirmed COVID cases [11]. It is encouraged for pharmacies in Australia to support remote dispensing of prescriptions using prescriptions received through mails/faxed/emailed or making use of electronic transfer of prescriptions (ETP) technology couples with home delivery services in particular for the old and vulnerable populations [12].

China, Colombia and elsewhere

Lower Middle-Income Countries (LMIC) are in a greater need for pharmacists’ support where patients are unable to afford the doctor fees for a consultation. In absence of a standard treatment the importance of provision of pharmaceutical care by pharmacists managing the COVID-19 cases increased many-folds [13]. Similarly a different set of attributes then the routine conditions were observed in the pharmaceutical care provided by the Chinese Community pharmacists in dealing with the pandemic situation including maintaining controlled work environment, provision of information and necessary medical supplies as well as ensuring the regular medication and counselling are managed at best to avoid undue patient visits to healthcare facilities. The Community pharmacists in China were made use all possible resources to perform their role as care providers and custodian of patient safety regarding medicine use. They used Mobile applications, coordination with neighbourhood committees and medicine companies to ensure delivery of medicines to patients in their homes [10]. The response to COVID-19 pandemic in countries have differed drastically. In Columbia, a lesser incidence of hospitalization and no intensive care need was attributed to better preparedness, higher exposure to multiple strains of viral respiratory infections as well as early adoption of containment strategies [14].

Pakistan and COVID-19

As of 6 April, there are 3059 confirmed cases & 45 deaths with COVID-19 in Pakistan [15]. Since the first case reported on 26 Feb 2020, Pakistan has put in place its mitigation strategies which are framed around suspension of flight operations both international and domestic, social distancing, point of entry screening, contact tracing, clinical management of COVID-19 patients, Home Quarantine and Isolation & burial procedures for COVID-19 patients [16] To ramp up the efforts of containing the spread of COVID-19, the federal government imposed a partial lockdown on 21 March 2020 in which schools and pupil places are closed. Public transport is suspended. Public Hospitals are turned into isolation wards and the working class has been advised to work from home. Bakeries, Utility Stores, vegetables shops and dairy shops are opened but that too between specific hours. People can come outside of their homes for essential trips and emergencies only [17]. After re-evaluating the situation based on increasing cases within Pakistan, federal government has extended the partial lockdown on 1 Apr 2020 for two more weeks [18].

Economical effects re-aligning the access to pharmacies during COVID-19 crisis in Pakistan

The response to this COVID-19 pandemic in the shape of social distancing requiring country lockdown and close of businesses, is a death sentence to the daily wagers and low working class in Pakistan. According to experts the number of people who can lose their jobs in various sectors are between 12.3 million and 18.5 million [19]. Although, Pakistan as a fragile and indebted economy has come up to the rescue of its vulnerable people with a multi-trillion-rupee relief package, allocating 200 billion rupees for the labour class. Under the package, some 10 million people, categorized under low-income groups, will get a lump sum amount of 12,000 PKR, initially for a period of four months in the form of Ehsaas Emergency Cash Program [20]. However, this amount is lower than the daily wages they were getting before lockdown [19]. These economically pressured masses don’t have much to spend on their health especially when the public hospitals have closed their OPDs for the general public. With no were to go and no money to spend, they access their nearby pharmacies which can get them medical advice without paying for consultation and they only have to pay for the medicine if it’s needed. This could be a great window to showcase the role of community pharmacists in LMICs particularly during a time of a health emergency.

Telemedicine, pharmacists and Pakistan

With the closure of OPDs in the private and public hospitals, there has been a great unrest among the patients with other diseases. With nowhere to go and to exercise and save themselves from the virus exposure at the hospitals, opens the door for Telemedicine provisioning in this time of crisis. There is a growing demand for telehealth and telemedicine has already been in use Pakistan for a while [21]. With the doctors, nurses and paramedics physically present in the emergency, isolation wards and quarantine centers, pharmacists can hold onto this end and can ease the patient distress by providing triaging and basic consultations via Telemedicine, taking the burden off the doctors and health system.

Development of the COVID-19 pharmacy guidelines in Pakistan

In Pakistan, majority of the pharmacists are engaged with the pharmaceutical industry, however there is a growing number which is now working in the community pharmacies or at retail pharmacies. While the organizations, authorities, hospitals were arranging personal protection equipment (PPEs) for doctors, nurses and paramedics, little attention was being paid towards the protection of pharmacy teams even though they are the first line of contact for the public in normal situation and even more in this COVID-19 pandemic with closing of public OPDs. Assessing this scenario worldwide, Pharmacists in the UK and in Pakistan team up together to compile 10-steps protection guidelines for the pharmacy teams in Pakistan in English and Urdu language. These guidelines are shown in Table 1.

Table 1 COVID-19 10 Step guidance for pharmacy teams

The COVID-19 guidance for pharmacy teams in Pakistan was endorsed by the Ministry of National Health Services, Regulation and Coordination (M/o NHSR&C) and supported by The International Pharmaceutical Federation (FIP), The Commonwealth Pharmacists Association (CPA), Drug Regulatory Body Pakistan (DRAP), Pakistan Pharmacists Association (PPA), one of Pakistan’s leading telemedicine providers – doctHERS, The National Alliance of Women in Pharmacy, Pakistan (NAWP) and Pharmacy Council Pakistan.

These guidelines can be adopted and adapted by any country keeping in view their own laws and regulations.


  1. Press release UK Government (April 2, 2020) £300 million announced for community pharmacies to support them during coronavirus outbreak, Available on: Accessed 05 April 2020.

  2. Rutter V, Chan AHY, Tuck C, Bader L, Babar Z-U-D, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018;11(1):10.

    Article  Google Scholar 

  3. NHS England and NHS Improvement. Novel coronavirus (COVID-19) standard operating procedure-Community Pharmacy. Available on: Accessed 05 April 2020.

  4. International Pharmaceutical Federation. Coronavirus/COVID-19 preparedness. Available on: Accessed 05 April 2020.

  5. American Pharmacist Association. Pharmacists’ Guide to Coronavirus. Available on: Accessed 05 April 2020.

  6. Pharmaceutical Group of European Union. Press Release-Community pharmacists in the frontline in the fight against the novel corona-virus disease (COVID-19). Available on: Accessed 05 April 2020.

  7. The United States Pharmacopoeia Commission. Hand Sanitizer Toolkit. Available on: Accessed 05 April 2020.

  8. Kottasova I, Donato VD. Women are using code words at pharmacies to escape domestic violence during lockdown: CNN; Available on: Accessed 05 April 2020.

  9. Osama M. Al-Quteimat and Amer Mustafa Amer, SARS-CoV-2 outbreak: how can pharmacists help? Res Social Adm Pharm. 2020. [In Press].

  10. Zheng S-q, et al. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: a China perspective. Res Social Adm Pharm. 2020. [In Press].

  11. Pharmaceutical Society of New Zealand (Inc.). COVID-19: Guidance Provided By The Society For Pharmacy. Available on: Accessed 05 April 2020.

  12. Australian Government Department of Health. Fact Sheet-Coronavirus (COVID-19) Health Plan, Primary Care-Home Medicine Services Response to COVID-19. Available on: Accessed 05 April 2020.

  13. Song Z, Hu Y, Zheng S, Yang L, Zhao R. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: recommendations and guidance from clinical experience. Res Social Adm Pharm. 2020. [In Press].

  14. Amariles P, et al. COVID-19 in Colombia endpoints. Are we different, like Europe? Res Social Adm Pharm. 2020.

  15. Government of Pakistan. COVID-19 Dashboard (last updated: 05-April-2020,7:48 pm). Available on: Accessed 06 April 2020.

  16. Government of Pakistan-Ministry of National Health Services, Regulations and Coordination. Advisory on mitigation strategies COVID-19. Available on: Accessed 05 April 2020.

  17. Saad, MA. Pakistan’s Fight Against the Coronavirus Threat. Available on: Accessed 05 April 2020.

  18. Government of Pakistan-Ministry of National Health Services, Regulations and Coordination. Official Website. Available on: Accessed 05 April 2020.

  19. Human Rights Watch. Pakistan: Workers Face Health, Economic Risks. Available on: Accessed 05 April 2020.

  20. Government of Pakistan, Poverty Alleviation and Social Safety Division. PM launches Ehsaas Emergency Cash initiative worth Rs. 144 billion to support 12 million needy families affected by COVID19 crisis. Available on;$gHaf9b4180-a491-4907-9ebf-2ee28d3067ba0ecFf65%5ES23d$Pd. Accessed 05 April 2020.

  21. Shah TK, Tariq T, Phillips R, et al. Health care for all: effective, community supported, healthcare with innovative use of telemedicine technology. J of Pharm Policy and Pract. 2018;11:3.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations



All authors participated in the conceptualisation, drafting and revision of the manuscript. The guidelines were developed by NB and BN. Thanks to HR for providing expert advice on the guidelines. All authors have read and approved the final text of the manuscript.

Authors’ information

Nadia Bukhari, BPharm (Hons), FRPharmS, FHEA, PG Dip Pharmacy Practice, PG Dip Teaching and Learning in Higher Education, is an academic pharmacist at University College London, Global Lead for Gender Equity at the International Pharmaceutical Federation (FIP) and Founder and Patron-in-Chief for the National Alliance for Women in Pharmacy (NAWP, Pakistan.

Huma Rasheed, BPharm, MPhil, PhD is an Assistant Professor in Pharmaceutics at Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan and also the President of National Alliance for Women in Pharmacy (NAWP) in Pakistan.

Bismah Nayyer, PharmD is managing the breast cancer initiative of the Ministry of National Health Services, Regulation & Coordination (M/o NHSR&C) Pakistan and has been a support in COVID-19 response groups. She is currently pursuing MsPH from King’s College London and also a member of National Alliance for Women in Pharmacy (NAWP) in Pakistan.

Zaheer-Ud-Din Babar, BPharm MPharm PhD SFHEA is the Professor in Medicines and Healthcare and the Director of Pharmaceutical Policy and Practice Research Centre at the Department of Pharmacy, University of Huddersfield, United Kingdom.

Corresponding author

Correspondence to Zaheer-Ud-Din Babar.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors approved the manuscript.

Competing interests

NB is the member of the international Advisory Board of Journal of Pharmaceutical Policy and Practice. ZUDB is the Editor in Chief of Journal of Pharmaceutical Policy and Practice.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bukhari, N., Rasheed, H., Nayyer, B. et al. Pharmacists at the frontline beating the COVID-19 pandemic. J of Pharm Policy and Pract 13, 8 (2020).

Download citation

  • Published:

  • DOI: